SMTL ID : 8huq.1

X-ray structure of human PPAR alpha ligand binding domain-elafibranor-SRC1 coactivator peptide co-crystals obtained by soaking

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 8 residues within 4Å: Chain A: K.27, R.31, L.34, S.127, S.128, M.130, N.131, N.171 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:R.31, A:S.128, A:M.130, A:N.171 Water bridges: A:K.27, A:N.131, A:E.174

1 x MUO: 2-[2,6-dimethyl-4-[(~{E})-3-(4-methylsulfanylphenyl)-3-oxidanylidene-prop-1-enyl]phenoxy]-2-methyl-propanoic acid(Non-covalent)

MUO.2: 21 residues within 4Å: Chain A: I.77, F.78, C.80, C.81, Q.82, T.84, S.85, Y.119, I.122, F.123, L.126, M.135, V.137, I.144, I.159, M.160, H.245, V.249, L.261, L.265, Y.269 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.77, A:F.78, A:F.78, A:Y.119, A:F.123, A:V.137, A:I.159 Hydrogen bonds: A:S.85, A:S.85 Salt bridges: A:H.245

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kamata, S. et al., Functional and Structural Insights into the Human PPAR alpha / delta / gamma Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor. Antioxidants (2023)

Release Date

2023-08-09

Peptides

Peroxisome proliferator-activated receptor alpha: A
15-meric peptide from Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Peroxisome proliferator-activated receptor alpha

15-meric peptide from Nuclear receptor coactivator 1

Related Entries With Identical Sequence